Prostate cancer cells home to bone using a novel in vivo model : modulation by the integrin antagonist GLPG 0187 Running title : new in vivo model for tracking early prostate cancer homing to bone
暂无分享,去创建一个
Nicola J Brown | F. Hamdy | N. Brown | M. Cecchini | J. Down | G. Pluijm | Freddie Hamdy | C. Eaton | Marco Cecchini | K. Reeves | Colby L Eaton | Gabri van der Pluijm | Kimberley J Reeves | Jack E Hurrell | Jenny M Down | Philippe Clement-Lacroix | P. Clément-Lacroix | Jack E. Hurrell
[1] S. Cross,et al. The angiogenic switch occurs at the adenoma stage of the adenoma–carcinoma sequence in colorectal cancer , 2007, Gut.
[2] N. Clarke,et al. bone marrow endothelium: binding , 2022 .
[3] K. Pienta,et al. An in vivo mouse model for human prostate cancer metastasis. , 2008, Neoplasia.
[4] O. Rokhlin,et al. Expression of cellular adhesion molecules on human prostate tumor cell lines , 1995, The Prostate.
[5] J. Rhim,et al. Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, follistatin, activin-A, and DHT. , 1999, International Journal of Oncology.
[6] L. Chung,et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. , 1994, Cancer research.
[7] A. Gown,et al. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. , 2008, Cancer research.
[8] M. Reed,et al. Evaluation of Fluorescent Plasma Markers for in vivo Microscopy of the Microcirculation , 2012, Journal of Vascular Research.
[9] Balázs Sarkadi,et al. The role of ABC transporters in drug resistance, metabolism and toxicity. , 2004, Current drug delivery.
[10] G. Risbridger,et al. An in vivo model of prostate carcinoma growth and invasion in bone , 2002, Cell and Tissue Research.
[11] N. Clarke,et al. Molecular mechanisms of metastasis in prostate cancer. , 2009, Asian journal of andrology.
[12] R. Luksch,et al. Expression of integrins in human bone marrow , 1990, British journal of haematology.
[13] S. Cross,et al. Microvascular Endothelial Cell Responses in vitro and in vivo: Modulation by Zoledronic Acid and Paclitaxel? , 2010, Journal of Vascular Research.
[14] S. Kukreja,et al. Patterns of metastasis by the human prostate cancer cell line PC‐3 in athymic nude mice , 1989, The Prostate.
[15] Ivo Que,et al. Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. , 2002, The American journal of pathology.
[16] K. Messmer,et al. Dorsal skinfold chamber technique for intravital microscopy in nude mice. , 1993, The American journal of pathology.
[17] M. Hung,et al. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[18] G. van der Pluijm,et al. Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. , 2011, The American journal of pathology.
[19] G. Jayson,et al. Alpha-v Integrins as Therapeutic Targets in Oncology , 2007, Cancer investigation.
[20] S. Jacobs. Spread of prostatic cancer to bone. , 1983, Urology.
[21] Joe W Gray,et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. , 2006, Cancer research.
[22] K. Honn,et al. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix , 1992, Cancer and Metastasis Reviews.
[23] R. Ganz,et al. Potential role of pre-existing blood vessels for vascularization and mineralization of osteochondral graftsAn intravital microscopic study in mice , 2004, Acta orthopaedica Scandinavica.
[24] R. Jain,et al. Angiogenesis and growth of isografted bone: quantitative in vivo assay in nude mice. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[25] P. Jiang,et al. Monitoring of skeletal progression of prostate cancer by GFP imaging, X‐ray, and serum OPG and PTHrP , 2005, The Prostate.
[26] I. Holen,et al. Imaging the effects of castration on bone turnover and hormone‐independent prostate cancer colonization of bone , 2008, The Prostate.
[27] J. Myers,et al. Metastasis of squamous cell carcinoma of the oral tongue , 2007, Cancer and Metastasis Reviews.
[28] E. Danen,et al. BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β3 expression , 2011, Cellular Oncology.
[29] R. Shah,et al. In Vivo Visualization of Metastatic Prostate Cancer and Quantitation of Disease Progression in Immunocompromised Mice , 2003, Cancer biology & therapy.
[30] T. Byzova,et al. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. , 2007, Oncogene.
[31] R. Nagle,et al. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. , 1994, Journal of cellular biochemistry. Supplement.
[32] I. Holen,et al. Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo , 2012, Clinical & Experimental Metastasis.
[33] R. Vessella,et al. Mechanisms, Hypotheses and Questions Regarding Prostate Cancer Micrometastases to Bone , 1998, Cancer and Metastasis Reviews.
[34] G. van der Pluijm,et al. Osteotropic cancers: from primary tumor to bone. , 2009, Cancer letters.
[35] M. Horton,et al. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor , 1989, The Journal of cell biology.
[36] C. Kao,et al. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines , 1998, International journal of cancer.
[37] W. Jiang,et al. Cell adhesion molecules and adhesion abnormalities in prostate cancer. , 2002, Critical reviews in oncology/hematology.
[38] M. Reed,et al. Macrophages promote angiogenesis in human breast tumour spheroids in vivo , 2005, British Journal of Cancer.
[39] J. Feyen,et al. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. , 2011, Neoplasia.
[40] K. Hillan,et al. Neutralizing anti‐vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo , 1998, The Prostate.